s-nitrosoglutathione has been researched along with Infarction, Middle Cerebral Artery in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhammu, TS; Khan, M; Kumar, P; Qiao, F; Singh, AK; Singh, I | 1 |
| Dhammu, TS; Khan, M; Matsuda, F; Singh, AK; Singh, I | 1 |
| Dhammu, TS; Khan, M; Sakakima, H; Shunmugavel, A; Singh, AK; Singh, I; Yoshida, Y | 1 |
| Dhammu, TS; Gilg, AG; Khan, M; Sakakima, H; Shunmugavel, A; Singh, AK; Singh, I | 1 |
4 other study(ies) available for s-nitrosoglutathione and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
Topics: Alcohol Dehydrogenase; Animals; Behavior, Animal; Benzamides; Brain; Brain Edema; Disease Models, Animal; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrroles; S-Nitrosoglutathione | 2019 |
Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy.
Topics: Adenylate Kinase; AMP-Activated Protein Kinase Kinases; Animals; Brain; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Peroxynitrous Acid; Phosphorylation; Protein Serine-Threonine Kinases; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; S-Nitrosoglutathione; Stroke | 2015 |
Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.
Topics: Analysis of Variance; Animals; Apoptosis; Brain Infarction; Brain-Derived Neurotrophic Factor; Caspase 3; Chromones; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Exercise Therapy; Gene Expression Regulation; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Locomotion; Male; Morpholines; Neuroprotective Agents; Oncogene Protein v-akt; Phosphopyruvate Hydratase; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptor, trkB; Recovery of Function; Reperfusion; S-Nitrosoglutathione; Severity of Illness Index; Time Factors | 2012 |
The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Carrier Proteins; Disease Models, Animal; E-Selectin; Endothelial Cells; Evans Blue; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Neoplasm Proteins; Neurons; Neuroprotective Agents; NF-kappaB-Inducing Kinase; Nitric Oxide; Nitrites; Nucleocytoplasmic Transport Proteins; Peroxynitrous Acid; Phosphopyruvate Hydratase; Protein Serine-Threonine Kinases; Protein Transport; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Statistics, Nonparametric; Time Factors; Tyrosine; Zonula Occludens-1 Protein | 2012 |